Hepatic siRNA delivery using recombinant human apolipoprotein A-I in mice

Biochemical and Biophysical Research Communications - Tập 378 - Trang 192-196 - 2009
Hyeon Lee1, Soo In Kim1, Duckhyang Shin1, Yeup Yoon1, Tae Hyun Choi2, Gi-Jeong Cheon2, Meehyein Kim1
1Virus Research Laboratory, Mogam Biotechnology Research Institute, 341 Bojeong-dong, Giheung-gu, Yongin-si, Gyeonggi-do 449-913, South Korea
2Emergency Medical Team and Nuclear Medicine Laboratory, National Radiation Emergency Medical Center, Korea Institute of Radiological and Medical Sciences, 215-4 Gongneung-dong, Nowon-gu, Seoul 139-706, South Korea

Tài liệu tham khảo

Takamizawa, 1991, Structure and organization of the hepatitis C virus genome isolated from human carriers, J. Virol., 65, 1105, 10.1128/JVI.65.3.1105-1113.1991 Grakoui, 1993, Expression and identification of hepatitis C virus polyprotein cleavage products, J. Virol., 67, 1385, 10.1128/JVI.67.3.1385-1395.1993 Shimotohno, 1995, Processing of the hepatitis C virus precursor protein, J. Hepatol., 22, 87 Anonymous, 2000, Hepatitis C--global prevalence (update), Wkly Epidemiol. Rec., 75, 18 Theodore, 2000, Natural history and disease manifestations of hepatitis C infection, Curr. Top. Microbiol. Immunol., 242, 43 Behrens, 1996, Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus, EMBO J., 15, 12, 10.1002/j.1460-2075.1996.tb00329.x Manns, 2001, Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial, Lancet, 358, 958, 10.1016/S0140-6736(01)06102-5 Elbashir, 2001, Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells, Nature, 411, 494, 10.1038/35078107 Hannon, 2002, RNA interference, Nature, 418, 244, 10.1038/418244a Nykanen, 2001, ATP requirements and small interfering RNA structure in the RNA interference pathway, Cell, 107, 309, 10.1016/S0092-8674(01)00547-5 Kapadia, 2003, Interference of hepatitis C virus RNA replication by short interfering RNAs, Proc. Natl. Acad. Sci. USA, 100, 2014, 10.1073/pnas.252783999 Kim, 2006, Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model, Virus Res., 122, 1, 10.1016/j.virusres.2006.05.003 Kim, 2007, Systemic and specific delivery of small interfering RNAs to the liver mediated by apolipoprotein A-I, Mol. Ther., 15, 1145, 10.1038/sj.mt.6300168 Nishina, 2008, Efficient in vivo delivery of siRNA to the liver by conjugation of alpha-tocopherol, Mol. Ther., 16, 734, 10.1038/mt.2008.14 Rozema, 2007, Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes, Proc. Natl. Acad. Sci. USA, 104, 12982, 10.1073/pnas.0703778104 Sato, 2008, Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone, Nat. Biotechnol., 26, 431, 10.1038/nbt1396 Gordon, 1983, Proteolytic processing of human preproapolipoprotein A-I. A proposed defect in the conversion of pro A-I to A-I in Tangier’s disease, J. Biol. Chem., 258, 4037, 10.1016/S0021-9258(18)32773-X Saku, 1999, In vivo kinetics of human apolipoprotein A-I variants in rabbits, Eur. J. Clin. Invest., 29, 196, 10.1046/j.1365-2362.1999.00430.x Xu, 1997, Apolipoproteins of HDL can directly mediate binding to the scavenger receptor SR-BI, an HDL receptor that mediates selective lipid uptake, J. Lipid Res., 38, 1289, 10.1016/S0022-2275(20)37413-7 Shin, 2007, Immunostimulatory properties and antiviral activity of modified HBV-specific siRNAs, Biochem. Biophys. Res. Commun., 364, 436, 10.1016/j.bbrc.2007.10.012 Panagotopulos, 2002, Bacterial expression and characterization of mature apolipoprotein A-I, Protein Expr. Purif., 25, 353, 10.1016/S1046-5928(02)00020-7 Shin, 2006, Efficient inhibition of hepatitis B virus replication by small interfering RNAs targeted to the viral X gene in mice, Virus Res., 119, 146, 10.1016/j.virusres.2005.12.012 Dang, 1995, Structure of the hepatic control region of the human apolipoprotein E/C-I gene locus, J. Biol. Chem., 270, 22577, 10.1074/jbc.270.38.22577 Le, 1997, Therapeutic levels of functional human factor X in rats after retroviral-mediated hepatic gene therapy, Blood, 89, 1254, 10.1182/blood.V89.4.1254 Lerch, 1996, Production and characterization of a reconstituted high density lipoprotein for therapeutic applications, Vox Sang., 71, 155, 10.1046/j.1423-0410.1996.7130155.x Templeton, 1997, Improved DNA: liposome complexes for increased systemic delivery and gene expression, Nat. Biotechnol., 15, 647, 10.1038/nbt0797-647 Hunter, 1970, Standardization of the chloramine-T method of protein iodination, Proc. Soc. Exp. Biol. Med., 133, 989, 10.3181/00379727-133-34611